Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

July 26, 2022 | CME, Medscape Oncology, medical education 

- PMLiVE

Spotlight on Lymphoma

Ahead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in lymphoma. Here are some of the highlights…

  1. Update on the ECHELON-1 study in frontline Hodgkin lymphoma, where an OS advantage was seen when bleomycin was replaced with brentuximab vedotin in frontline, ABVD, which is potentially practice-changing.
  2. The results of the Ph 3 SHINE study have been eagerly awaited for many years in untreated mantle cell lymphoma, and showed a significant improvement in PFS with ibrutinib + bendamustine + rituximab and rituximab maintenance vs standard chemoimmunotherapy.
  3. Positive Ph 2 efficacy data with the bispecific antibodies, glofitamab for relapsed/refractory (R/R) diffuse large B-cell lymphoma, and mosunetuzumab for R/R follicular lymphoma, building on the Ph 1 data previously reported.
  4. Other CAR T-cell therapies with novel targets and in other indications are emerging, such as for T-cell lymphoma where there is a high unmet need for new therapies. Some manipulations to manufacturing also result in an auto CAR within 2 days. So, while CAR T-cell therapy is not new, there are new implementations of therapy that have been around for several years.
  5. Important to now learn regarding patient selection, sequencing CD19 directed therapy and how to account for the patient experience for which there will also be more PRO data reported.

You can also watch the full video here

About Medscape:
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

Contagious Conversations: Exploring Infectious Disease in the Digital Age

As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...

Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens

From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...

Impacting Lives with Rare Disease Education

Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...

Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D

An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...

A Rare Disease Update from Medscape Education

A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency

New Outcomes Are a Breath of Fresh Air at ERS

ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Protecting the Heart Through Education at ESC 2023

Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...

Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners

The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...

Continuing Medical Education Outcomes are Much More Than Statistical Significance

At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...